Azetidine

Azetidine

SCHEMBL5691838

C1CNC1.Cc1ccc(C(=O)O)c(C)c1

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFE2L2 Q16236 1/20 0.49
▸ CSNK2A1 P68400 1/20 0.48
▸ KDM4E B2RXH2 2/20 0.43
▸ HSD11B1 P28845 1/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ RXRB P28702 2/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA4 P22748 1/20 0.42
▸ CA6 P23280 1/20 0.42
▸ MAOB P27338 1/20 0.42
▸ CA5A P35218 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA14 Q9ULX7 1/20 0.42
▸ CA5B Q9Y2D0 1/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclopropane SCHEMBL5080442 0.89 CSNK2A1 (0.52) NFE2L2CSNK2A1KDM4EHSD11B1NPC1
SCHEMBL107259 0.88 CSNK2A1 (0.59) NFE2L2CSNK2A1KDM4EHSD11B1RXRB
SCHEMBL30679777 0.88 CSNK2A1 (0.59) NFE2L2CSNK2A1KDM4EHSD11B1RXRB
Bromide SCHEMBL6113400 0.86 CSNK2A1 (0.57) NFE2L2CSNK2A1KDM4EHSD11B1NPC1
SCHEMBL6915319 0.86 CSNK2A1 (0.57) NFE2L2CSNK2A1KDM4EHSD11B1NPC1
SCHEMBL6912721 0.86 CSNK2A1 (0.57) NFE2L2CSNK2A1KDM4EHSD11B1NPC1
SCHEMBL6915656 0.86 CSNK2A1 (0.57) NFE2L2CSNK2A1KDM4EHSD11B1NPC1
SCHEMBL6916723 0.86 CSNK2A1 (0.57) NFE2L2CSNK2A1KDM4EHSD11B1NPC1
SCHEMBL6908325 0.86 CSNK2A1 (0.57) NFE2L2CSNK2A1KDM4EHSD11B1NPC1
Charcoal, Activated SCHEMBL7747676 0.86 CSNK2A1 (0.57) NFE2L2CSNK2A1KDM4EHSD11B1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001974-B1 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARM INC (US) 2006-05-24 — — EP disclosed
Send feedback